Stata DX

United States
Primghar, Iowa, United States

Company profile

Stata DX company profile

Stata DX is a developer of a disease management eRapid technology designed to implement custom biomarker panels for at-home patient monitoring in clinical studies. The company's technology is a low-cost, affinity-based electrochemical sensing platform that can simultaneously detect a wide range of biomarkers in complex biological fluids, specifically liquid MRI for the brain, with high sensitivity and selectivity using as little as a single drop of blood, allowing researchers to learn about the composition of a system in real-time. Stata DX was established in Cambridge, Massachusetts.

Business identity

Operating status
Active
Company type
For Profit
Employee range
1-10 employees
Revenue range
$0+
Founded
2022-01-01, Year

Headquarters

Country code
US
Continent
North America

Capital profile

Funding and company signals

Funding stage
Early Stage Venture
Funding rounds
2
Total equity funding
$3.2M
Last funding
Series A / $500,000 / 2024-03-13
Last equity funding
Series A / $500,000
Investors
1

Founders and investors

Investors

MassVentures